Log in

NASDAQ:ABEOAbeona Therapeutics SEC Filings & 10K Form

$2.92
+0.02 (+0.69 %)
(As of 06/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.87
Now: $2.92
$3.03
50-Day Range
$2.27
MA: $2.79
$3.31
52-Week Range
$1.35
Now: $2.92
$5.60
Volume770,834 shs
Average Volume1.17 million shs
Market Capitalization$244.40 million
P/E RatioN/A
Dividend YieldN/A
Beta1.63

SEC Filings

Abeona Therapeutics (NASDAQ:ABEO) SEC Filings

DateFilerForm TypeView
05/22/2020
5:21 PM
Abeona Therapeutics (Issuer)
Tomasello Shawn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
5:20 PM
Abeona Therapeutics (Issuer)
Wider Todd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
5:17 PM
Abeona Therapeutics (Issuer)
Silverstein Christine Berni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
5:15 PM
Abeona Therapeutics (Issuer)
Rouhandeh Steven H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
5:13 PM
Abeona Therapeutics (Issuer)
Siffert Joao MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
5:10 PM
Abeona Therapeutics (Issuer)
Howell Stephen B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
5:07 PM
Abeona Therapeutics (Issuer)
CARR EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
5:05 PM
Abeona Therapeutics (Issuer)
Buono Stefano (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2020
3:42 PM
Abeona Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/21/2020
3:38 PM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2020
3:06 PM
Abeona Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/23/2020
4:13 PM
Abeona Therapeutics (Filer)
Form DEFA14A
04/22/2020
4:17 PM
Abeona Therapeutics (Subject)
GREAT POINT PARTNERS LLC (Filed by)
Form SC 13D/A
04/21/2020
3:54 PM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2020
6:03 PM
Abeona Therapeutics (Issuer)
Pereira Brian JG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2020
6:02 PM
Abeona Therapeutics (Issuer)
Pereira Brian JG (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/10/2020
10:20 AM
Abeona Therapeutics (Filer)
Form DEF 14A
04/06/2020
3:15 PM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2020
3:38 PM
Abeona Therapeutics (Issuer)
CARR EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2020
3:36 PM
Abeona Therapeutics (Issuer)
Rouhandeh Steven H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2020
3:28 PM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2020
2:13 PM
Abeona Therapeutics (Subject)
CVI Investments, Inc. (Filed by)
Form SC 13G/A
02/06/2020
4:03 PM
Abeona Therapeutics (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SC 13G/A
01/28/2020
10:49 AM
Abeona Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/08/2020
3:35 PM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2020
4:18 PM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2019
4:17 PM
Abeona Therapeutics (Issuer)
Buono Stefano (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2019
12:07 PM
Abeona Therapeutics (Subject)
GREAT POINT PARTNERS LLC (Filed by)
Form SC 13D
12/27/2019
8:23 AM
Abeona Therapeutics (Subject)
CVI Investments, Inc. (Filed by)
Form SC 13G
12/26/2019
5:05 AM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2019
4:22 PM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2019
4:17 PM
Abeona Therapeutics (Filer)
Form 424B5
12/20/2019
3:34 PM
Abeona Therapeutics (Subject)
The Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
12/10/2019
4:11 PM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
3:38 PM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2019
7:50 AM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2019
3:15 PM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2019
9:58 AM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2019
4:51 PM
Abeona Therapeutics (Issuer)
CARR EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2019
3:16 PM
Abeona Therapeutics (Subject)
GREAT POINT PARTNERS LLC (Filed by)
Form SC 13G
09/10/2019
10:19 AM
Abeona Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
09/04/2019
3:07 PM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2019
3:23 PM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2019
3:01 PM
Abeona Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/25/2019
8:20 AM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2019
8:10 AM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2019
1:58 PM
Abeona Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
07/05/2019
7:22 AM
Abeona Therapeutics (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SC 13G
05/23/2019
7:34 PM
Abeona Therapeutics (Issuer)
Alvino Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
5:28 PM
Abeona Therapeutics (Issuer)
Buono Stefano (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
5:27 PM
Abeona Therapeutics (Issuer)
Howell Stephen B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
5:25 PM
Abeona Therapeutics (Issuer)
Wider Todd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
5:23 PM
Abeona Therapeutics (Issuer)
Van Duyne Richard B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
4:10 PM
Abeona Therapeutics (Issuer)
Howell Stephen B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
3:23 PM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2019
3:11 PM
Abeona Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/18/2019
4:58 PM
Abeona Therapeutics (Issuer)
Silverstein Christine Berni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2019
4:58 PM
Abeona Therapeutics (Issuer)
Siffert Joao MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2019
4:57 PM
Abeona Therapeutics (Issuer)
Van Duyne Richard B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2019
4:57 PM
Abeona Therapeutics (Issuer)
CARR EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2019
9:20 AM
Abeona Therapeutics (Issuer)
Buono Stefano (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2019
6:06 PM
Abeona Therapeutics (Issuer)
Rouhandeh Steven H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2019
6:00 PM
Abeona Therapeutics (Issuer)
Miller Timothy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2019
5:57 PM
Abeona Therapeutics (Issuer)
CARR EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2019
5:54 PM
Abeona Therapeutics (Issuer)
Siffert Joao MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2019
5:52 PM
Abeona Therapeutics (Issuer)
Silverstein Christine Berni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2019
4:10 PM
Abeona Therapeutics (Filer)
Form DEF 14A
04/11/2019
3:05 PM
Abeona Therapeutics (Issuer)
Siffert Joao MD (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/11/2019
3:05 PM
Abeona Therapeutics (Issuer)
Silverstein Christine Berni (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/11/2019
3:05 PM
Abeona Therapeutics (Issuer)
CARR EDWARD (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/10/2019
5:39 PM
Abeona Therapeutics (Issuer)
Howell Stephen B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2019
5:36 PM
Abeona Therapeutics (Issuer)
Howell Stephen B. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/03/2019
9:51 AM
Abeona Therapeutics (Filer)
Form CT ORDER
03/18/2019
4:10 PM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
12:48 PM
Abeona Therapeutics (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G
02/13/2019
4:00 PM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2019
12:24 PM
Abeona Therapeutics (Subject)
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Form SC 13G/A
01/10/2019
4:01 PM
Abeona Therapeutics (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13G/A
01/10/2019
7:30 AM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2018
1:06 PM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/29/2018
6:46 PM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2018
3:50 PM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2018
7:31 AM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2018
3:40 PM
Abeona Therapeutics (Filer)
Form 8-K/A
08/17/2018
7:20 PM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/17/2018
4:19 PM
Abeona Therapeutics (Filer)
Form 424B5
08/16/2018
4:28 PM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2018
3:36 PM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2018
3:04 PM
Abeona Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/30/2018
3:29 PM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2018
11:15 PM
Abeona Therapeutics (Filer)
Form EFFECT
06/01/2018
3:17 PM
Abeona Therapeutics (Filer)
Form S-3/A
05/23/2018
6:32 PM
Abeona Therapeutics (Issuer)
Buono Stefano (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2018
6:24 PM
Abeona Therapeutics (Issuer)
Van Duyne Richard B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2018
5:12 PM
Abeona Therapeutics (Issuer)
Buono Stefano (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/21/2018
5:05 PM
Abeona Therapeutics (Issuer)
Van Duyne Richard B (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/14/2018
4:22 PM
Abeona Therapeutics (Filer)
Form 8-K/A
05/11/2018
3:12 PM
Abeona Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/10/2018
4:21 PM
Abeona Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/09/2018
6:49 PM
Abeona Therapeutics (Filer)
Form DEF 14A
This page was last updated on 6/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.